Goal
Rapidly repair fractured bones without the need for metal plates or screws.
Problem
Current fracture fixation requires invasive surgery and permanent metal implants, leading to infection risk and foreign-body reactions.
Concept Summary
A bio-inspired medical adhesive that mimics oyster cement. It can be injected into a fracture site, hardens within 2-3 minutes in a moist, blood-rich environment, bonds bone fragments with high strength, and is naturally absorbed as the bone heals.
Detailed Description
Bone-02 is an organic-inorganic hybrid adhesive derived from the principles of oyster shell cement. The formulation contains calcium carbonate crystals, a cross-linked protein matrix, and water. When injected into a fracture, the adhesive reacts with physiological fluids, causing rapid crystallization and polymerization that creates a strong bond between bone fragments. Laboratory tests reported a maximum bonding force of >400 lb, shear strength of ~0.5 MPa, and compressive strength of ~10 MPa. The material is designed to be bio-resorbable, gradually degrading as new bone forms, thus eliminating the need for a second surgery for implant removal.
Principles
- Bio-inspired adhesion (oyster cement)
- Calcium carbonate mineralization
- Protein cross-linking in moist environments
Scientific Domains
Materials
- Calcium carbonate (CaCO_3)
- Adhes proteins (derived from oyster cement analogues)
- Water
Mechanisms of Action
- In situ crystallization of calcium carbonate on bone surfaces
- Cross-linked protein matrix providing mechanical cohesion
- Rapid hardening in the presence of blood and interstitial fluid
Applications
- Orthopedic fracture repair
- Bone fixation without metal hardware
Claimed Performance
Bonding force >400 lb, shear strength ~=0.5 MPa, compressive strength ~=10 MPa; sets in 2-3 minutes; fully resorbable as bone heals.
Experimental Evidence
Laboratory tests confirmed the mechanical strengths and setting time; one clinical trial case reported complete fixation in <3 minutes compared with traditional surgery.
Replication Status
Only reported by the originating research team; no independent replication documented.
Limitations
- Limited clinical data; only early-stage trials reported
- Potential variability in performance in highly vascularized (blood-rich) sites